title: Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
authors.forename: Sabai
authors.initials: S
authors.lastname: Phyu
authors.forename: Ti
authors.initials: T
authors.lastname: Ti
authors.forename: Roland
authors.initials: R
authors.lastname: Jureen
authors.forename: Thandar
authors.initials: T
authors.lastname: Hmun
authors.forename: Hlaing
authors.initials: H
authors.lastname: Myint
authors.forename: Aye
authors.initials: A
authors.lastname: Htun
authors.forename: Harleen M S
authors.initials: HM
authors.lastname: Grewal
authors.forename: Bjarne
authors.initials: B
authors.lastname: Bjorvatn
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications; D024881:Drug Resistance, Bacterial; D004977:Ethambutol / Q000494:pharmacology; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D002052:Myanmar / Q000453:epidemiology; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D011718:Pyrazinamide / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D017211:Treatment Failure; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology
chemical_list: D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin